AACPN welcomes House passage of legislation delaying most federal restrictions on consumable hemp products through December 11, providing Congress additional time to develop a comprehensive regulatory framework.

Originally published by the Hartford Courant, John R. Gordon examines Connecticut’s approach to hemp regulation amid an evolving national policy debate and considers the implications of proposed federal restrictions for the state’s existing regulatory framework.

Reps. Beth Van Duyne and Greg Landsman have introduced the bipartisan Beverage Regulatory Parity Act, proposing federal standards for hemp-derived beverages ahead of the November 12 deadline. AACPN founder and Marine Corps veteran Adrian Bruneau is quoted in the congressional announcement.

The American Alternative Care Policy Network has launched its Veterans Equal Access Initiative and formally endorsed federal legislation that would restore equal healthcare access for veterans by allowing VA physicians to discuss and recommend medical cannabis where permitted by state law.

The White House has urged Congress to reconsider forthcoming federal hemp restrictions and instead pursue a comprehensive regulatory framework. AACPN welcomes the recommendation and outlines why responsible regulation, consumer protection, and evidence-based policymaking offer a stronger path forward than prohibition.

The American Alternative Care Policy Network (AACPN) has announced a national policy agenda focused on expanding access to evidence-based integrative and alternative healthcare. Through its Alternative Care Access Campaign, Psychedelic Research Initiative, and Hemp Beverage Policy Initiative, AACPN seeks to advance healthcare access, scientific research, patient choice, and evidence-based policy for veterans, trauma survivors, first responders, and other underserved populatio

AACPN applauds Connecticut’s enactment of Public Act 26-108, expanding the state’s psychedelic-assisted therapy pilot program and supporting continued clinical research involving MDMA and psilocybin therapies for veterans, first responders, trauma survivors, and individuals living with treatment-resistant mental health conditions.

AACPN welcomes the U.S. Department of Veterans Affairs’ launch of a clinical trial evaluating MDMA-assisted therapy for veterans living with PTSD and alcohol use disorder. The organization says rigorous scientific research is essential to understanding whether emerging therapies can safely and effectively support veterans and other trauma survivors facing complex behavioral health challenges.

The American Alternative Care Policy Network (AACPN) welcomes the unanimous passage of Louisiana legislation establishing a state-backed psychedelic-assisted therapy research initiative focused on mental health and substance-use disorders. The legislation reflects growing bipartisan recognition that treatment-resistant mental illness, PTSD, addiction, and veteran suicide require continued exploration of evidence-informed therapeutic innovation and expanded clinical research.

The American Alternative Care Policy Network (AACPN) today announced its launch, establishing a policy-driven platform to accelerate the integration of evidence-based alternative therapies into the U.S. healthcare system—where they can deliver measurable outcomes, expand access, and reduce long-term costs. AACPN enters a fragmented and often unserious policy environment with a clear mandate: impose rigor, elevate standards, and translate validated therapies into actionable le

The American Alternative Care Policy Network (AACPN) today issued the following statement in response to the Department of Justice’s decision to reclassify marijuana as a Schedule III substance under the Controlled Substances Act: “The Department of Justice’s decision to reschedule marijuana from Schedule I to Schedule III marks a meaningful, if overdue, shift in federal policy. By recognizing accepted medical use, this action begins to correct a long-standing misalignment be

The American Alternative Care Policy Network (AACPN) today issued the following statement in response to the White House executive order, “Breakthrough Mental Health Treatments — Delivering New Hope to Veterans,” which accelerates research and access to emerging therapies for serious mental illness: “The administration’s executive order represents a consequential shift in federal mental health policy—one that recognizes a hard truth: for millions of Americans suffering from..